Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | Hepatitiden

Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities. 

Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities. 

Estadt AT, Kline D, Miller WC, Feinberg J, Hurt CB, Mixson LS, Friedmann PD, Lowe K, Tsui JI, Young AM, Cooper H, Korthuis PT, Pho MT, Jenkins W, Westergaard RP, Go VF, Brook D, Smith G, Rice DR, Lancaster KE. 

Harm Reduct J. 2024 Nov 29;21(1):214. doi: 10.1186/s12954-024-01131-6. PMID: 39614319; PMCID: PMC11606200.

https://pmc.ncbi.nlm.nih.gov/articles/PMC11606200/